Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Glaxosmithkline Plc (GSK)

2014-10-20@20:58:47 ET
GlaxoSmithKline plcCorporate Event Announcement Notice (WSH)

2014-10-20@13:11:45 ET
GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Support At $43.34 (FBM)

2014-10-20@09:20:00 ET
Earnings Releases, Conference Call Schedule, Acquisitions, Drug Launches, and Initiation of Study - Research Reports on KeyCorp, Itau Unibanco, BD, Mylan and GlaxoSmithKline (PRN)

2014-10-20@09:00:00 ET
ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. (PRN)

2014-10-20@08:33:16 ET
ADR Top % Movers in Pre-Market Trading (MID)

2014-10-18@14:14:57 ET
South Korea's ambitions in medical tourism (ABW)

2014-10-17@07:10:34 ET
Novartis Presents Encouraging Data on Leukemia Candidate (ZAX)

2014-10-17@06:22:57 ET
8-K: THERAVANCE INC (EDK)

2014-10-16@15:32:20 ET
GlaxoSmithKline: New 52-Week Low Set Today (GSK) (F71)

2014-10-16@14:16:50 ET
GlaxoSmithKline PLC (GSK) Trading Near $41.96 Support Level (FBM)

2014-10-16@13:15:00 ET
Despite Generic Erosion of Several Key Brands, the Renal Cell Carcinoma (RCC) Market Will Experience Modest Growth through 2023 (PRN)

2014-10-16@10:26:59 ET
GlaxoSmithKline Has Returned 16.6% Since SmarTrend Recommendation (GSK) (PSM)

2014-10-16@08:28:57 ET
ADR Top % Movers in Pre-Market Trading (MID)

2014-10-16@06:33:38 ET
Ebola Viral Infections Therapeutics Pipeline Review, H2 2014 Report - 23 Companies & 30+ Drug Profiles (MTO)

2014-10-15@18:00:05 ET
Watch for GlaxoSmithKline to Potentially Rebound After Falling 1.26% Yesterday (PSM)

2014-10-15@17:59:35 ET
Watch for GlaxoSmithKline to Potentially Rebound After Falling 1.26% Yesterday (PSM)

2014-10-15@12:00:00 ET
In the Face of Sales Erosion of Key Brands by Novel Formulations, GlaxoSmithKline/Theravance's LABA/LAMA Anoro Will Become the Leading COPD Agent in 2023 (PRN)

2014-10-15@11:00:00 ET
While Rheumatologists Would Welcome Novel Biologics for the Treatment of Systemic Lupus Erythematosus (SLE), Reimbursement Challenges Are Expected (PRN)

2014-10-15@08:30:10 ET
GlaxoSmithKline PLC (GSK) Trading Near $43.26 Support Level (FBM)

2014-10-15@04:34:58 ET
Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014 (MTO)